Sanofi delivered close to double digit Q4 2020 business EPS growth at CER

Fourth quarter and full-year 2020 results were reviewed by management during a live audio webcast with the financial community.
Fourth quarter and full-year 2020 results were followed by a virtual Capital Markets Day (CMD21).

Webcast details

I am incredibly proud of the measurable progress we made in 2020 even in the face of a global pandemic. We'll stay the course in 2021, focused on bringing breakthrough medicines and vaccines to people around the world.

Paul Hudson
Chief Executive Officer

FY 2020 infographic

Paul Hudson comments on FY 2020 results